聚甘油注射劑市場規模、佔有率和成長分析：按集中度、應用、最終用戶、分銷管道、包裝和地區分類 - 產業預測，2026-2033年

2024 年全球聚甘油注射劑市場價值為 5.124 億美元，預計到 2033 年將從 2025 年的 5.3751 億美元成長至 7.811 億美元，在預測期（2026-2033 年）內以 4.9% 的複合成長率成長。

全球注射聚甘油血漿（polygerin）市場的發展動力源於醫療保健系統對高效且經濟的液體療法的迫切需求，其核心是無菌血漿代用品，可在手術和創傷治療期間有效恢復血管內容量。聚甘油血漿最初因其價格比人體血清蛋白更實惠而廣受歡迎，如今，隨著手術數量的增加和各國政府採購力度的加大，市場規模顯著成長。在預算緊張的醫療機構中，液體容量補充療法的應用尤為突出，醫療機構正致力於降低與白蛋白和合成晶體液相關的成本。這使得聚甘油血漿更具吸引力，尤其是在公共醫療領域。此外，簡化的監管流程也使新參與企業能夠透過創新的包裝解決方案來增強其市場滲透率。

全球聚甘油注射劑市場的成長要素

醫療機構中微創手術的日益普及顯著提升了對高效補液方案的需求，而聚甘油注射液因其卓越的安全性和便捷的給藥方式而成為首選方案。醫護人員高度重視其快速起效和與多種麻醉方法的兼容性，有助於簡化手術流程並提高病患周轉率。因此，越來越多的醫療機構將聚甘油注射液應用於臨床實踐，形成了穩定的需求。這促使生產商拓展產品線和分銷通路。這一趨勢最終有助於改善臨床療效，同時也有助於控制營運成本。

全球聚甘油注射劑市場的限制因素

全球聚甘油注射劑市場面臨許多限制因素，主要源自於對注射用膠體製劑嚴格的監管，尤其是出於對免疫抗原性反應的擔憂，這些反應可能導致脆弱患者出現不利事件。這種高度警惕要求提供詳盡的臨床文件和持續的上市後監測，以支持其安全性聲明，從而延長了核准流程並增加了研發成本。製造商被迫投入更多資源來遵守嚴格的標籤要求並實施有效的風險緩解策略，這可能會阻礙產品及時上市並限制市場准入。因此，醫療專業人員往往會推遲採用這些產品，直到獲得可靠的安全性數據，這可能會減緩整體市場成長。

全球聚甘油注射劑市場趨勢

全球聚甘油注射劑市場正呈現出採用先進無菌包裝技術的顯著趨勢，這反映了各方為提升產品完整性和最大限度降低污染風險所做的努力。雙腔管瓶和先進阻隔膜等創新技術正日益普及，使生產商能夠延長聚甘油注射的保存期限。這一趨勢不僅提高了醫護人員的操作便利性，促進了門診和新興診所的廣泛應用，也增強了品牌差異化。為了滿足日益成長的病患安全期望，並配合全球供應鏈最佳化策略，這項轉變將為供應商帶來永續成長和更高的盈利，從而增強其市場競爭優勢。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球聚甘油注射劑市場規模：依濃度分類

• 3.5% 聚皂苷
• 其他準備工作

全球聚甘油注射劑市場規模：按應用領域分類

• 低血容量
• 手術輸液
• 創傷護理

全球聚甘油注射劑市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 急診中心

全球聚甘油注射劑市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球聚甘油注射劑市場規模：依包裝規格分類

• 玻璃瓶
• 軟性袋

全球聚甘油注射劑市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• B. Braun SE
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• Grifols, SA
• CSL Limited
• Octapharma AG
• Kedrion SpA
• Biotest AG
• Takeda Pharmaceutical Company Limited
• Shanghai RAAS Blood Products Co., Ltd.
• China Biologic Products Holdings, Inc.
• Green Cross Holdings Corporation
• Intas Pharmaceuticals Limited
• Jubilant Pharmova Limited
• Pfizer Inc.
• Otsuka Holdings Co., Ltd.
• JW Holdings Corporation
• Kelun Pharmaceutical Co., Ltd.
• Vifor Pharma Management Ltd.
• Bharat Serums and Vaccines Limited

結論與建議

Global Polygeline Injection Market size was valued at USD 512.4 Million in 2024 and is poised to grow from USD 537.51 Million in 2025 to USD 788.11 Million by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).

The global polygeline injection market is centered around a sterile plasma substitute that effectively restores intravascular volume during surgical procedures and trauma care, driven by the essential need for efficient and cost-effective fluid therapy across healthcare systems. Initially popularized as a more affordable option to human albumin, the market has seen significant expansion due to rising surgical procedures and increasing government procurement initiatives in various regions. The growing trend of adopting volume-expanding therapies in budget-conscious healthcare settings is evident, as institutions focus on reducing costs associated with albumin and synthetic crystalloids. This has notably increased polygeline's appeal, particularly in public healthcare sectors, while streamlined regulatory processes enable new entrants to enhance market penetration with innovative packaging solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polygeline Injection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Polygeline Injection Market Segments Analysis

Global polygeline injection market is segmented by concentration, application, end user, distribution channel, packaging and region. Based on concentration, the market is segmented into 3.5% polygeline and other formulations. Based on application, the market is segmented into hypovolemia, surgical volume replacement and trauma care. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and emergency care centers. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on packaging, the market is segmented into glass bottles and flexible bags. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Polygeline Injection Market

The rising adoption of minimally invasive surgeries in healthcare facilities is significantly boosting the demand for effective volume expanders, with polygeline injection emerging as a top choice thanks to its strong safety profile and straightforward administration. Medical professionals appreciate its quick action and compatibility with diverse anesthesia methods, which streamline procedures and improve patient flow. As a result, healthcare providers are increasingly integrating polygeline into their practices, leading to a consistent demand that encourages manufacturers to broaden their product offerings and distribution channels. This trend ultimately enhances clinical outcomes while aiding in the management of operational costs.

Restraints in the Global Polygeline Injection Market

The Global Polygeline Injection market faces significant constraints stemming from the rigorous oversight imposed by regulatory agencies regarding injectable colloids, primarily due to concerns about potential immunogenic responses that could result in adverse effects for vulnerable patients. This heightened vigilance necessitates thorough clinical documentation and ongoing post-marketing surveillance to substantiate safety claims, resulting in prolonged approval processes and elevated development costs. Manufacturers are compelled to invest extra resources to adhere to stringent labeling requirements and implement effective risk mitigation strategies, which can hinder timely product launches and restrict market access. As a result, healthcare providers may be inclined to delay their adoption of these products until robust safety data is available, thereby slowing down overall market growth.

Market Trends of the Global Polygeline Injection Market

The Global Polygeline Injection market is witnessing a notable trend toward the adoption of advanced sterile packaging technologies, reflecting a commitment to enhance product integrity and minimize contamination risks. Innovations such as dual-chamber vials and advanced barrier films are becoming increasingly prevalent, allowing manufacturers to extend the shelf-life of polygeline injections. This trend not only improves handling convenience for healthcare providers, facilitating wider use in outpatient settings and emerging clinics, but also strengthens brand differentiation. By meeting rising patient safety expectations and aligning with global supply chain optimization efforts, this shift positions suppliers for sustained growth and increased profitability, reinforcing their competitive edge in the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Polygeline Injection Market Size by Concentration & CAGR (2026-2033)

• Market Overview
• 3.5% Polygeline
• Other Formulations

Global Polygeline Injection Market Size by Application & CAGR (2026-2033)

• Market Overview
• Hypovolemia
• Surgical Volume Replacement
• Trauma Care

Global Polygeline Injection Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Emergency Care Centers

Global Polygeline Injection Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Polygeline Injection Market Size by Packaging & CAGR (2026-2033)

• Market Overview
• Glass Bottles
• Flexible Bags

Global Polygeline Injection Market Size & CAGR (2026-2033)

• North America (Concentration, Application, End User, Distribution Channel, Packaging)
  • US
  • Canada
• Europe (Concentration, Application, End User, Distribution Channel, Packaging)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Concentration, Application, End User, Distribution Channel, Packaging)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Concentration, Application, End User, Distribution Channel, Packaging)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Concentration, Application, End User, Distribution Channel, Packaging)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotest AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Green Cross Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Pharmova Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kelun Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vifor Pharma Management Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Serums and Vaccines Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations